{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:36:17Z","timestamp":1790840177537,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.09.023","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T18:00:10Z","timestamp":1191261610000},"page":"7743-7753","source":"Crossref","is-referenced-by-count":32,"title":["Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Melamed","family":"Sharon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paran","family":"Nir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katz","family":"Lior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Nathan","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israely","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schneider","family":"Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levin","family":"Reuven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lustig","family":"Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.09.023_bib1","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"issue":"12","key":"10.1016\/j.vaccine.2007.09.023_bib2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1201-1271","article-title":"Bioterrorism: a clear and present danger","volume":"7","author":"Lane","year":"2001","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.vaccine.2007.09.023_bib3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/423851","article-title":"Clinical and immune responses after revaccination of Israeli adults with the Lister strain of Vaccinia virus","volume":"190","author":"Orr","year":"2004","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.023_bib4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.vaccine.2007.09.023_bib5","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"Empig","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.023_bib6","first-page":"289","article-title":"Mouse models for studying orthopoxvirus respiratory infections","volume":"269","author":"Schriewer","year":"2004","journal-title":"Meth Mol Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.023_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/14787210.4.2.277","article-title":"Smallpox antiviral drug development: satisfying the animal efficacy rule","volume":"4","author":"Jordan","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2007.09.023_bib8","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1099\/0022-1317-80-10-2751","article-title":"A model for Vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae","volume":"80","author":"Tscharke","year":"1999","journal-title":"J Gen Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.09.023_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2005.05.027","article-title":"Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera","volume":"130","author":"Eyal","year":"2005","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2007.09.023_bib10","series-title":"Strains of Human Viruses","author":"Majer","year":"1972"},{"key":"10.1016\/j.vaccine.2007.09.023_bib11","first-page":"36","article-title":"Preparation of vaccine against smallpox in chorioalantois membranes of chicken embryos","volume":"9","author":"Gerichter","year":"1966","journal-title":"Public Health (Israeli Ministry of Health, Jerusalem)"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2007.09.023_bib12","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1099\/vir.0.82068-0","article-title":"Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara","volume":"87","author":"Staib","year":"2006","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.09.023_bib13","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1073\/pnas.89.7.2679","article-title":"Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation","volume":"89","author":"Hahn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.09.023_bib14","series-title":"Statistical Methods in Biological Assays","author":"Finney","year":"1952"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.023_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"issue":"19","key":"10.1016\/j.vaccine.2007.09.023_bib16","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2007.09.023_bib17","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.09.023_bib18","first-page":"493","article-title":"A simple method of estimating fifty percent end points","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"5406","key":"10.1016\/j.vaccine.2007.09.023_bib19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.023_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/eid0703.017311","article-title":"Outbreak of human monkeypox, Democratic Republic of Congo, 1996\u20131997","volume":"7","author":"Hutin","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.09.023_bib21","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1086\/498155","article-title":"Reemergence of monkeypox: prevalence, diagnostics, and countermeasures","volume":"41","author":"Nalca","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.023_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.290.1.23","article-title":"Monkeypox outbreak a reminder of emerging infections vulnerabilities","volume":"290","author":"Stephenson","year":"2003","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.vaccine.2007.09.023_bib23","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"10.1016\/j.vaccine.2007.09.023_bib24","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1016\/j.vaccine.2005.02.005","article-title":"Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model","volume":"23","author":"Phelps","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.023_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vaccine.2006.07.022","article-title":"Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine","volume":"25","author":"Phelps","year":"2007","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2007.09.023_bib26","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2006.02.012","article-title":"Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA)","volume":"24","author":"Abdalrhman","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.023_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2005.06.043","article-title":"The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection","volume":"341","author":"Coulibaly","year":"2005","journal-title":"Virology"},{"issue":"47\u201348","key":"10.1016\/j.vaccine.2007.09.023_bib28","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.023_bib29","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1128\/JVI.02642-05","article-title":"LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox","volume":"80","author":"Saijo","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.09.023_bib30","series-title":"Emerging infections 7","first-page":"343","article-title":"Smallpox vaccination: a review of adverse events for contemporary health care providers","author":"Fulginiti","year":"2007"},{"issue":"17","key":"10.1016\/j.vaccine.2007.09.023_bib31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.023_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after revaccination against smallpox","volume":"161","author":"el-Ad","year":"1990","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2007.09.023_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","article-title":"Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees","volume":"7","author":"Viner","year":"2005","journal-title":"Microbes Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2007.09.023_bib34","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2007.09.023_bib35","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00018-006-6313-2","article-title":"Keeping the memory of smallpox virus","volume":"63","author":"Puissant","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.023_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0264-410X(98)00197-2","article-title":"Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination","volume":"17","author":"Stienlauf","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.023_bib37","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4049\/jimmunol.178.3.1654","article-title":"Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules","volume":"178","author":"Dasgupta","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.023_bib38","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.66.5.2617-2630.1992","article-title":"Molecular attenuation of vaccinia virus: mutant generation and animal characterization","volume":"66","author":"Lee","year":"1992","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.023_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","volume":"339","author":"Meseda","year":"2005","journal-title":"Virology"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2007.09.023_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/icb.1989.48","article-title":"Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice","volume":"67","author":"Andrew","year":"1989","journal-title":"Immunol Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T23:33:51Z","timestamp":1587944031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":40,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07010201"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}